Search Results 81-90 of 9231 for Mediate
Immune-Mediated Megaconial Myopathy: A Novel Subtype of Autoimmune Myopathy. Neurology. 2024 Nov 26; 103 (10):e210001 Epub 2024 Oct 30. View PubMed; Santilli ...
Rochester, Minn. The purpose of this study is to provide expanded access of patisiran to patients with hereditary transthyretin-mediated amyloidosis (hATTR).
A Study of the Safety and Effectiveness of Eculizumab to Prevent Antibody-Mediated Rejection in ABO Blood Group Incompatible Living Donor Kidney Transplantation.
A Study to Evaluate the Efficacy and Safety of AKCEA-TTR-LRx in Participants with Hereditary Transthyretin-Mediated Amyloid Polyneuropathy · Overview.
While mechanical cues have long been implicated in shaping lung development, more research is needed to understand how they differentially manifest and mediate ...
Steroid cell tumor of the ovary causing renin-mediated hypertension: A case from the endocrine teaching clinics. Sept. 15, 2018. A 37-year-old woman was ...
... mediated kidney transplant rejection. In addition, oral corticosteroid treatment significantly alters the frequency and function of Breg subsets, which ...
In contrast, protein IX and hexon-mediated targeting by the same set of ligands failed to mediate robust vector targeting, perhaps due to aberrant ...
How does autoinflammatory disease differ from autoimmune-mediated seizures? Both conditions present as refractory epilepsy with no clear etiology. But in ...
... Mediated Amyloidosis in Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran) Rochester, MN. The purpose of this study is to evaluate the safety ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.